RESUMEN
The small Indian mongoose (Herpestes auropunctatus) is a rabies reservoir in areas of the Caribbean including Puerto Rico, but no rabies vaccination program targeting this host exists. We used two derivatives of iophenoxic acid (IPA) to evaluate placebo oral rabies vaccine bait uptake by mongooses in southwestern Puerto Rico. We hand-distributed baits at an application rate of 200 baits/km2 at three, 400 ha, sites during autumn 2016 and spring 2017. Each site contained 90-100 cage traps in a 100 ha central trapping area. We used ethyl-IPA as a biological marker during the autumn and methyl-IPA during the spring. We live captured mongooses for 10 consecutive days, beginning 1 wk following bait application. We obtained a serum sample from captured mongooses and analyzed the sera for ethyl- and methyl-IPA by liquid chromatography-mass spectrometry. During autumn 2016, 63% (55/87) mongooses sampled were positive for ethyl-IPA. In spring 2017, 69% (85/123) of mongooses were positive for methyl-IPA. Pooling seasons, accounting for recaptures between years, and disregarding marker type, 74% (133/179) unique mongooses were positive for IPA biomarker, indicating bait consumption during either the autumn, spring, or both trials. We conclude that distributing baits at an application rate of 200 baits/km2 is sufficient to reach over 60% of the target mongoose population in dry forest habitats of Puerto Rico.
Asunto(s)
Reservorios de Enfermedades/veterinaria , Vacunas Antirrábicas/inmunología , Rabia/veterinaria , Administración Oral , Animales , Biomarcadores/sangre , Reservorios de Enfermedades/virología , Herpestidae , Hispánicos o Latinos , Ácido Yopanoico/administración & dosificación , Ácido Yopanoico/metabolismo , Puerto Rico , Rabia/prevención & control , Vacunas Antirrábicas/administración & dosificación , VacunaciónRESUMEN
The oral vaccination of wild badgers (Meles meles) with live Bacillus Calmette-Guérin (BCG) is one of the tools being considered for the control of bovine tuberculosis (caused by Mycobacterium bovis) in the UK. The design of a product for oral vaccination requires that numerous, and often competing, conditions are met. These include the need for a highly palatable, but physically stable bait that will meet regulatory requirements, and one which is also compatible with the vaccine formulation; in this case live BCG. In collaboration with two commercial bait companies we have developed a highly attractive and palatable bait recipe designed specifically for European badgers (Meles meles) that meets these requirements. The palatability of different batches of bait was evaluated against a standardised palatable control bait using captive badgers. The physical properties of the bait are described e.g. firmness and colour. The microbial load in the bait was assessed against European and US Pharmacopoeias. The bait was combined with an edible vaccine carrier made of hydrogenated peanut oil in which BCG vaccine was stable during bait manufacture and cold storage, demonstrating <0.5 log10 reduction in titre after 117weeks' storage at -20°C. BCG stability in bait was also evaluated at +4°C and under simulated environmental conditions (20°C, 98% Relative Humidity; RH). Finally, iophenoxic acid biomarkers were utilised as a surrogate for the BCG vaccine, to test variants of the vaccine-bait design for their ability to deliver biomarker to the gastrointestinal tract of individual animals. These data provide the first detailed description of a bait-vaccine delivery system developed specifically for the oral vaccination of badgers against Mycobacterium bovis using live BCG.
Asunto(s)
Vacuna BCG/administración & dosificación , Reservorios de Enfermedades/microbiología , Mustelidae/inmunología , Mycobacterium bovis/inmunología , Tuberculosis Bovina/prevención & control , Vacunación/métodos , Administración Oral , Animales , Bovinos , Sistemas de Liberación de Medicamentos/métodos , Ácido Yopanoico/administración & dosificación , Mustelidae/microbiología , Tuberculosis Bovina/inmunología , Tuberculosis Bovina/microbiología , Potencia de la Vacuna , Vacunas ComestiblesRESUMEN
Iophenoxic acid and its derivatives (methyl, ethyl, and propyl) are organic chemicals used as markers in baiting campaigns to deliver vaccines, pharmaceuticals, contraceptives or poisons to wildlife. In this study we develop a method of detection of IPA derivatives by LC/ESI-MS (using butyl-IPA as internal standard) obtaining a limit of detection and quantification in wild boar (Sus scrofa) serum of 0.037 microg/ml and 0.123 microg/ml, respectively. The average recovery of IPA derivatives was 88% at levels >0.2 microg/ml, with coefficients of variation <15%. Wild boars in captivity were orally treated with 5 mg/kg b.w. (three adults) or 15 mg/kg b.w (two piglets and three adults) of methyl-, ethyl- and propyl-IPA and the serum levels of these were monitored during 18 months after dosing. Ethyl- and propyl-IPA were detected up to 18 months after a single oral dose in wild boar, especially at 15 mg/kg. Methyl-IPA was detected until 9 months after dosing. Half-lives of methyl-, ethyl- and propyl-IPA were (mean+/-SD) 41+/-5, 183+/-85 and 165+/-45 days, respectively. One control piglet not exposed to IPA, but housed in the same facility than treated animals showed detectable IPA levels in serum. Piglets born from mothers exposed to marked baits also showed detectable IPA levels in serum. The high persistence of Et- and Pr-IPA must be considered in the field trials, because the presence of the product at low levels in one animal may not reflect a real ingestion of the marked bait.
Asunto(s)
Ácido Yopanoico/análogos & derivados , Espectrometría de Masa por Ionización de Electrospray/métodos , Sus scrofa/sangre , Drogas Veterinarias/análisis , Administración Oral , Animales , Animales Salvajes/sangre , Biomarcadores/análisis , Sistemas de Liberación de Medicamentos , Femenino , Ácido Yopanoico/administración & dosificación , Ácido Yopanoico/análisis , Masculino , Drogas Veterinarias/administración & dosificaciónAsunto(s)
Anestesia Intravenosa , Antitiroideos/efectos adversos , Enfermedad Hepática Inducida por Sustancias y Drogas/etiología , Enfermedad de Graves/cirugía , Ácido Yopanoico/uso terapéutico , Metimazol/efectos adversos , Cuidados Preoperatorios/métodos , Tiroidectomía , Antagonistas Adrenérgicos beta/uso terapéutico , Adulto , Antitiroideos/uso terapéutico , Dexametasona/administración & dosificación , Dexametasona/uso terapéutico , Quimioterapia Combinada , Femenino , Enfermedad de Graves/tratamiento farmacológico , Humanos , Hipertensión/inducido químicamente , Hipertensión/tratamiento farmacológico , Ácido Yopanoico/administración & dosificación , Ácido Yopanoico/efectos adversos , Enfermedades Renales/prevención & control , Propranolol/administración & dosificación , Propranolol/uso terapéutico , Taquicardia/inducido químicamente , Taquicardia/tratamiento farmacológicoRESUMEN
OBJECTIVES: To develop an encapsulation method for delivery of vaccines to feral pigs, and quantify the effect of iophenoxic acid on captive feral pig blood iodine concentrations to assist in investigation of factors affecting vaccine uptake. DESIGN AND METHODS: Feral pigs were administered iophenoxic acid by oral gavage, and consumption was assessed for different encapsulation methods in baits. Blood iodine concentrations were monitored for eight days after consumption. The relationship between dose rate, time since dosing and blood iodine concentration was assessed for gavaged and baited captive feral pigs. Wild feral pigs were baited with PIGOUT baits containing 20 mg of encapsulated iophenoxic acid to simulate a vaccination program. Using knowledge from the pen studies, bait uptake and factors affecting bait uptake were investigated. RESULTS: Bait-delivered iophenoxic acid led to variable and inconsistent changes in blood iodine concentrations, in contrast to pigs receiving iophenoxic acid by gavage. This precluded accurate assessment of the quantity consumed, but still allowed a conservative determination of bait uptake. Iophenoxic acid in smaller capsules was consumed readily. Increasing baiting intensity appeared to increase bait uptake by wild feral pigs, and pigs of varying sexes, ages and weights appeared equally likely to consume baits. CONCLUSIONS: Encapsulated liquids can be delivered to feral pigs within baits, should the need to vaccinate feral pigs for fertility or disease management arise. High baiting intensities may be required.
Asunto(s)
Ácido Yopanoico/análogos & derivados , Enfermedades de los Porcinos/prevención & control , Vacunación/veterinaria , Administración Oral , Animales , Animales Recién Nacidos , Sistemas de Liberación de Medicamentos/veterinaria , Yodo/sangre , Ácido Yopanoico/administración & dosificación , Ácido Yopanoico/farmacocinética , Porcinos/metabolismo , Resultado del TratamientoRESUMEN
BACKGROUND AND AIMS: Amiodarone-induced thyrotoxicosis is a life-threatening condition. A prompt control of thyrotoxicosis is obtained by thyroidectomy. Preparation with iopanoic acid proved to be very effective in reducing cardiovascular complications. Nevertheless, general anesthesia and extensive surgery may affect negatively patients also after adequate preparation. Safety and efficacy of minimally invasive video-assisted thyroidectomy performed under regional anesthesia (bilateral modified deep cervical block) in patients with amiodarone-induced thyrotoxicosis was evaluated. PATIENTS AND METHODS: Eight patients with amiodarone-induced thyrotoxicosis (three with type I and five with type II), mean age 66.2 years, were prepared with iopanoic acid. There were five men and three women. Three patients had dilatative cardiomyopathy, three had heart failure secondary to severe myocardial infarction, and two had refractory unstable rhythm disorders. RESULTS: Minimally invasive video-assisted thyroidectomy was performed under regional anesthesia. Mean operative time was 55.5 min. During surgery, lung and heart function remained well and no surgical complications occurred. After surgery, all patients remained on amiodarone therapy and two patients were subsequently removed from the checklist for heart transplantation. CONCLUSION: Minimally invasive video-assisted thyroidectomy under regional anesthesia can be proposed as resolution of amiodarone-induced thyrotoxicosis in high risk patients with severe cardiac disorders, after preparation with iopanoic acid.
Asunto(s)
Amiodarona/toxicidad , Anestesia Local , Antiarrítmicos/toxicidad , Bloqueo Nervioso Autónomo , Bocio Nodular/inducido químicamente , Bocio Nodular/cirugía , Cardiopatías/complicaciones , Cardiopatías/tratamiento farmacológico , Ácido Yopanoico/administración & dosificación , Procedimientos Quirúrgicos Mínimamente Invasivos/métodos , Tiroidectomía/métodos , Tirotoxicosis/inducido químicamente , Tirotoxicosis/cirugía , Cirugía Asistida por Video/métodos , Anciano , Amiodarona/uso terapéutico , Antiarrítmicos/uso terapéutico , Arritmias Cardíacas/complicaciones , Arritmias Cardíacas/tratamiento farmacológico , Cardiomiopatía Dilatada/complicaciones , Cardiomiopatía Dilatada/tratamiento farmacológico , Femenino , Bocio Nodular/sangre , Indicadores de Salud , Insuficiencia Cardíaca/complicaciones , Insuficiencia Cardíaca/tratamiento farmacológico , Humanos , Masculino , Persona de Mediana Edad , Infarto del Miocardio/complicaciones , Infarto del Miocardio/tratamiento farmacológico , Premedicación , Tirotoxicosis/sangre , Tiroxina/sangre , Triyodotironina/sangreRESUMEN
This study was carried out to assess whether Rhodamine B, ethyl-iophenoxic acid (EtIPA), and propyl-iophenoxic acid (PrIPA) can be used as long-lasting systemic bait markers for free-living badgers (Meles meles). Between June and November 2003, these chemicals were incorporated into bait distributed around badger setts. Serum, hair, and whiskers from individually marked badgers were collected in the following 4 to 24 wk. Rhodamine B was detectable as fluorescent bands up to 24 wk after ingestion of the bait. Individual badgers were found positive for EtIPA and PrIPA up to 20 wk and 18 wk after exposure, respectively. This study indicates that Rhodamine B, PrIPA, and EtIPA could be used as long-lasting markers for badgers.
Asunto(s)
Ácido Yopanoico/análogos & derivados , Mustelidae , Rodaminas/administración & dosificación , Rodaminas/farmacocinética , Administración Oral , Animales , Animales Salvajes , Biomarcadores/análisis , Femenino , Colorantes Fluorescentes/análisis , Cabello/química , Ácido Yopanoico/administración & dosificación , Ácido Yopanoico/farmacocinética , Masculino , Mustelidae/metabolismo , Factores de TiempoRESUMEN
Fasting is characterized by disrupted thyroid feedback, with suppressed levels of thyroid hormones and paraventricular thyrotropin releasing hormone (TRH). We found that third ventricle administration of the deiodinase inhibitor, iopanoic acid, dose-dependently reduced deiodinase type II (DII) activity selectively in the hypothalamus. This suppression of DII by iopanoic acid during fasting prevented elevated DII activity and blunted the decline in hypothalamic TRH mRNA levels. Because fasting-induced elevation in hypothalamic DII activity is paralleled by increased hypothalamic T3 concentration, our study suggests that T3 formation by DII in the hypothalamus is the cause of disrupted thyroid feedback during fasting.
Asunto(s)
Ayuno , Hipotálamo/enzimología , Yoduro Peroxidasa/metabolismo , ARN Mensajero/metabolismo , Hormona Liberadora de Tirotropina/metabolismo , Animales , Relación Dosis-Respuesta a Droga , Retroalimentación Fisiológica , Hipotálamo/citología , Hipotálamo/efectos de los fármacos , Hibridación in Situ , Yoduro Peroxidasa/antagonistas & inhibidores , Ácido Yopanoico/administración & dosificación , Ácido Yopanoico/farmacología , Masculino , Ratas , Ratas Sprague-Dawley , Hormona Liberadora de Tirotropina/genética , Triyodotironina/metabolismoRESUMEN
The purpose of this study was to report our initial experience with a swine model for biliary interventions by using a percutaneous transcholecystic access after suture anchor of the gallbladder. Telepaque tablets were given to five pigs to opacify the gallbladder. Under fluoroscopy, the opacified gallbladder was punctured percutaneously and three suture anchors were used to fix the anterior wall of the gallbladder to the abdominal wall. Two weeks later, the gallbladder was punctured and access into the distal common bile was obtained through the cystic duct. Balloon expandable stents were deployed into the distal common bile duct. Follow-up cholangiograms were obtained at 1 and 2 weeks. Necropsy was performed after 2 weeks to evaluate the relationship between the gallbladder and abdominal wall. Suture anchor placement was successful in all five pigs. One pig with a deep and highly positioned gallbladder developed fever, anorexia, and vomiting secondary to excessive stretch of the gallbladder. Placement of the guidewire through the extremely tortuous and small cystic ducts proved to be the most challenging step of the procedure. Metallic stents were successfully deployed in all four pigs in which it was attempted. Four animals tolerated the procedures without changes in their clinical conditions and no symptoms. Successful follow-up cholangiograms were performed at 1 and 2 weeks post-stent deployment without complications. All stents remained patent during the follow-up period. Necropsy demonstrated close attachment and adherence of the gallbladders to the antero-lateral abdominal wall in all four animals. Suture anchoring of the gallbladder is feasible in most pigs with superficially located gallbladders. This technique allows a safe and repeat access into the biliary system using a transcholecystic approach.
Asunto(s)
Enfermedades de las Vías Biliares/cirugía , Vesícula Biliar/cirugía , Stents , Animales , Enfermedades de las Vías Biliares/diagnóstico por imagen , Medios de Contraste , Modelos Animales de Enfermedad , Estudios de Factibilidad , Fluoroscopía , Ácido Yopanoico/administración & dosificación , Punciones , Radiografía Intervencional , Técnicas de Sutura , PorcinosRESUMEN
OBJECTIVE: To describe our experience of CT (Computed tomographic) Cholangiography examination for detection of choledocholithiasis at the Aga Khan University Hospital (AKUH) Karachi Pakistan. METHODS: Seven patients underwent helical CT cholangiography for suspected choledocholithiasis. Iopanoic acid (6 grams) was administered orally 8-12 hours before acquisition of a helical CT cholangiogram. Three-dimensional reconstructions and curved multiplanar reformations were generated from a set of axial source images. RESULTS: Our patients had no adverse reactions to iopanoic acid. The degree of biliary opacification was sufficient to perform three-dimensional and curved planar reformations in 5 patients. In two patients, the biliary tree was not opacified. Both of these studies were considered failures. Findings on CT cholangiography in the remaining 5 patients were the following: cholelithiasis with normal bile duct (n=2), choledocholithiasis (n=1), stone in gallbladder remnant with long cystic duct (n=1) and infiltrating adenocarcinoma of the gallbladder (n=1). CONCLUSION: Spiral CT cholangiography is a safe, non-invasive, and cost effective alternative test and, in a carefully selected patient population can play a role in the diagnostic work-up of patients with suspected choledocholithiasis.
Asunto(s)
Colangiografía , Coledocolitiasis/diagnóstico por imagen , Ácido Yopanoico , Tomografía Computarizada por Rayos X , Administración Oral , Adulto , Anciano , Medios de Contraste/administración & dosificación , Femenino , Humanos , Ácido Yopanoico/administración & dosificación , Masculino , Persona de Mediana Edad , PakistánRESUMEN
OBJECTIVE: Traditionally, neonatal thyrotoxicosis has been managed with antithyroid drugs and/or iodine as well as sedatives, propranol and digitalis when necessary. The purpose of this study was to evaluate the management of neonatal thyrotoxicosis using the radio-contrast agent iopanoic acid. METHODS: We managed five cases of neonatal thyrotoxicosis. All infants were treated initially with propranolol (1.7 mg/kg/day) and iopanoic acid 250 to 500 mg every third or fourth day. RESULTS: In all cases, clinical signs improved and T(3) and T(4) levels decreased dramatically within 24 to 72 hours. No toxic side effects were noted. CONCLUSION: Neonatal thyrotoxicosis can be managed successfully using iopanoic acid. Iopanoic acid is essentially free of side effects and need only be administered every 3 to 4 days. When administered until (transplacental) maternal TSI has been metabolized by the neonate, iopanoic acid maintains euthyroid status with no risk of hypothyroidism. With conventional therapy, propylthiouracil (PTU) must be administered three times a day. PTU also carries a significant risk of toxic side effects and a week or more of therapy is required to correct the hyperthyroid state and may induce hypothyroidism.
Asunto(s)
Medios de Contraste/uso terapéutico , Enfermedad de Graves/tratamiento farmacológico , Ácido Yopanoico/uso terapéutico , Antagonistas Adrenérgicos beta/uso terapéutico , Medios de Contraste/administración & dosificación , Humanos , Inmunoglobulinas Estimulantes de la Tiroides/sangre , Recién Nacido , Ácido Yopanoico/administración & dosificación , Propranolol/uso terapéuticoRESUMEN
AIM: In this study, we describe our experience in treating subacute thyroiditis patients with 2 OCAs (sodium ipodate and sodium iopanoate). METHODS: We studied 10 consecutive patients with subacute thyroiditis treated with 1 of the 2 oral cholecystography agents (OCAs). RESULTS: Hyperthyroidism was controlled and symptoms improved markedly in each case without any evidence of subsequent relapse of thyroiditis after withdrawal of OCAs. Three of the 10 patients had been treated previously with corticosteroids and had demonstrated relapse of thyroiditis and hyperthyroidism after tapering or withdrawal of steroids. We observed no side effects of treatment with OCAs. CONCLUSION: Our data suggest that OCAs are effective and safe agents for management of hyperthyroidism in patients with subacute thyroiditis, even when they have relapsed after treatment with corticosteroids.
Asunto(s)
Medios de Contraste/administración & dosificación , Hipertiroidismo/tratamiento farmacológico , Hipertiroidismo/etiología , Ácido Yopanoico/análogos & derivados , Ácido Yopanoico/administración & dosificación , Ipodato/administración & dosificación , Tiroiditis Subaguda/complicaciones , Enfermedad Aguda , Administración Oral , Adulto , Anciano , Colecistografía , Femenino , Humanos , Masculino , Persona de Mediana EdadRESUMEN
BACKGROUND: Amiodarone-induced thyrotoxicosis (AIT) may develop either in apparently normal glands (type II AIT) or in the presence of thyroid abnormalities (type I AIT). Sometimes AIT is resistant to conventional treatment. Thyroidectomy was used in patients with AIT, but in patients who are thyrotoxic it may be hazardous. METHODS; Seven patients with AIT (6 type I and 1 type II, 5 men, 2 women, mean age 70 years [range, 60-82 years]) were prepared for total thyroidectomy with a short course of iopanoic acid (1 g/day orally for a mean of 13 days), an oral iodinated cholecystographic agent inhibiting 5'-deiodinase and causing a reduction in the peripheral conversion of thyroxine to triiodothyronine. Mean thyroid volume was 64 mL (range, 10-145 mL). RESULTS: Mean serum-free triiodothyronine levels decreased from 20 +/- 16.7 pmol/L to 6 +/- 2 pmol/L (P =.0004), whereas serum-free thyroxine values remained unchanged. Euthyroidism was rapidly (7-20 days) restored, allowing an uncomplicated total thyroidectomy in all patients and the ability to continue amiodarone therapy in 6 patients. None had increased surgical bleeding, recurrent nerve palsy, or hypoparathyroidism. No cardiovascular complications occurred. CONCLUSIONS: Iopanoic acid is an effective drug allowing rapid control of hyperthyroidism in AIT.
Asunto(s)
Amiodarona/efectos adversos , Medios de Contraste/administración & dosificación , Inhibidores Enzimáticos/efectos adversos , Ácido Yopanoico/administración & dosificación , Tiroidectomía , Tirotoxicosis/tratamiento farmacológico , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Hipertiroidismo/inducido químicamente , Hipertiroidismo/tratamiento farmacológico , Masculino , Persona de Mediana Edad , Cuidados Preoperatorios , Tirotoxicosis/inducido químicamenteRESUMEN
OBJECTIVE: We evaluated the feasibility and image quality of a new noninvasive biliary imaging technique: helical CT cholangiography with three-dimensional volume rendering using an oral biliary contrast agent. SUBJECTS AND METHODS: Nineteen subjects including five healthy volunteers and 14 patients underwent helical CT cholangiography. Subjects ingested 6.0 g of iopanoic acid 6-10 hr before undergoing imaging. Axial data were used to construct three-dimensional volume-rendered cholangiograms. Two radiologists, an endoscopist, and a laparoscopic surgeon reviewed the images and evaluated overall image quality. In the 14 patients, findings from CT cholangiography were compared with those from ERCP, surgery, and intraoperative cholangiography. RESULTS: All segments of the biliary tree were opacified in all volunteers except one, in whom the intrahepatic ducts were not opacified. Image quality was good to excellent in all volunteers. Anomalous cystic duct insertions were seen in two volunteers. Opacification of the biliary tree was rated as acceptable to excellent in nine patients and suboptimal in five. In five patients with good or excellent opacification, the biliary anatomy correlated with findings on intraoperative cholangiography or ERCP. CT cholangiography revealed additional conditions (gallbladder varices and acute pancreatitis) and variant anatomy in three patients. CONCLUSION: Results of this pilot project suggest that obtaining CT cholangiograms using an oral biliary contrast agent is a feasible, noninvasive method for revealing biliary anatomy. However, visualization of the biliary tree was suboptimal in 36% of the patients, which represents a limitation of this technique.
Asunto(s)
Enfermedades de las Vías Biliares/diagnóstico por imagen , Colangiografía/métodos , Medios de Contraste , Ácido Yopanoico , Tomografía Computarizada por Rayos X/métodos , Administración Oral , Adulto , Medios de Contraste/administración & dosificación , Estudios de Factibilidad , Femenino , Humanos , Ácido Yopanoico/administración & dosificación , Masculino , Persona de Mediana EdadRESUMEN
Twenty asymptomatic volunteers underwent helical computed tomographic (CT) cholangiography 10-12 hours after ingesting iopanoic acid. Three observers assessed the images for the extent of bile duct visualization and image quality. The common bile duct and common hepatic duct were adequately visualized in 19 (95%) subjects. Helical CT cholangiography with oral cholecystographic contrast material is feasible and deserves further clinical studies.
Asunto(s)
Colangiografía , Medios de Contraste/administración & dosificación , Ácido Yopanoico , Tomografía Computarizada por Rayos X , Administración Oral , Adulto , Anciano , Artefactos , Conductos Biliares Intrahepáticos/diagnóstico por imagen , Colecistectomía , Colecistografía , Conducto Colédoco/diagnóstico por imagen , Conducto Cístico/diagnóstico por imagen , Estudios de Factibilidad , Femenino , Conducto Hepático Común/diagnóstico por imagen , Humanos , Aumento de la Imagen , Procesamiento de Imagen Asistido por Computador/métodos , Ácido Yopanoico/administración & dosificación , Hígado/diagnóstico por imagen , Masculino , Persona de Mediana Edad , Factores de TiempoRESUMEN
PURPOSE: To investigate the capabilities of Helical CT in imaging the biliary tract after administration of an oral cholecystographic contrast agent. MATERIAL AND METHODS: Forty-five adult patients and one 8-year-old child were examined with Helical CT 12 hours after the oral administration of hyopanoic acid (3 g). All the examinations were performed with the following parameters: thickness 5 mm, pitch factor 1.5, standard reconstruction algorithm, acquisition time 20-30 s, image index 2.5 mm, 130 kV, 125 mA. In 37 cases CT was performed in patients candidate to laparoscopic cholecystectomy, in 8 cases to assess the positioning of surgical clips in patients with postcholecystectomy syndrome and in 1 case (the 8-year-old child) to confirm the US diagnosis of choledochal cystic dilatation. Helical CT images were reconstructed with a Volume Rendering (VR) software. RESULTS: The extrahepatic biliary tract was visualized in all the cases with CT and VR. II grade biliary ducts were visualized in 87% (CT) and 91% (VR), III grade ducts in 76% (CT) and 78% (VR), IV grade ducts in 28% and 35%, respectively. No statistically significant difference was found between CT and VR in the visualization of the biliary structures (p > 0.05), while three-dimensional VR reconstructions improved the evaluation of the anatomical relations in the biliary tract in comparison with CT both in normal cases and in patients with congenital abnormalities of the biliary tract. Also, three-dimensional VR reconstructions were superior in assessing the correct positioning of surgical clips in patients with postcholecystectomy syndrome (p < 0.05). DISCUSSION AND CONCLUSIONS: Cholecysto-cholangio-CT with VR reconstructions is a reliable imaging technique for the biliary tract in patients candidate to laparoscopic cholecystectomy, to diagnose choledochal cystic dilatation and to assess the positioning of surgical clips.
Asunto(s)
Conductos Biliares Extrahepáticos/diagnóstico por imagen , Conductos Biliares Intrahepáticos/diagnóstico por imagen , Colecistectomía Laparoscópica , Tomografía Computarizada por Rayos X/métodos , Administración Oral , Adulto , Niño , Medios de Contraste/administración & dosificación , Femenino , Humanos , Procesamiento de Imagen Asistido por Computador , Ácido Yopanoico/administración & dosificación , Masculino , Persona de Mediana EdadRESUMEN
As there is a possibility that Se influences the growth of animals via thyroid hormone metabolism, the following three experiments were undertaken in order to determine the effects of dietary Se on growth, skeletal muscle protein turnover and thyroid hormone status in broiler chickens. Broiler chickens were raised on a Se-deficient diet until 12 d of age and then used for the experiments. In Experiment 1, twenty-eight birds were randomly assigned to four groups and fed purified diets with the following amounts of Se supplementation: 0.0, 0.1, 0.3 and 0.5 mg Se/kg diet. Dietary Se supplementation significantly increased plasma 3,5,3'-triiodothyronine (T3) concentration and improved growth, while plasma thyroxine (T4) concentration was decreased. In Experiment 2, twenty-eight birds were assigned to four groups and fed either a Se-deficient diet or a Se-supplemented diet (0.3 mg Se/kg diet) with or without the supplementation of iopanoic acid, a specific inhibitor of 5'-deiodinase (5 mg/kg diet). The growth was promoted and feed efficiency was improved by dietary Se supplementation as was also observed in Experiment 1. However, this effect of Se was halted by iopanoic acid supplementation. Hepatic 5'-deiodinase activity was elevated by Se and inhibited by iopanoic acid. In Experiment 3, birds were fed on the following diets to show that Se influences growth of birds via thyroid hormone metabolism: Se-deficient diet, Se-supplemented diets (0.1 and 0.3 mg/kg) and T3 supplemented diets (0.1 and 0.3 mg/kg diet). Lower dietary T3 supplementation (0.1 mg/kg diet) resulted in growth promotion similar to Se supplementation, while higher level of T3 caused growth depression. Furthermore, it was observed that the rate of skeletal muscle protein breakdown tended to be increased by Se similarly to the effect of T3. In conclusion, it was shown in the present study that Se deficiency depresses growth of broilers by inhibiting hepatic 5'-deiodinase activity which causes lower plasma T3 concentration.
Asunto(s)
Pollos/crecimiento & desarrollo , Yoduro Peroxidasa/análisis , Desarrollo de Músculos , Músculo Esquelético/crecimiento & desarrollo , Selenio/fisiología , Hormonas Tiroideas/fisiología , Análisis de Varianza , Animales , Ácido Yopanoico/administración & dosificación , Masculino , Músculo Esquelético/metabolismo , Selenio/administración & dosificación , Selenio/deficienciaRESUMEN
OBJECTIVE: The objective of this investigation was to assess the performance of helical CT cholangiography after administration of an oral biliary contrast agent for the diagnosis of choledocholithiasis. SUBJECTS AND METHODS: Helical CT cholangiography was performed on 31 patients referred for endoscopic retrograde cholangiography of suspected choledocholithiasis. Iopanoic acid (6 g) was administered orally 8-12 hr before acquisition of helical CT cholangiograms. Three-dimensional and two-dimensional reformations were generated from a set of axial source images. Two radiologists independently interpreted the helical CT cholangiograms. Sensitivity and specificity were calculated using findings on retrograde cholangiography as the standard of reference. In addition, interobserver agreement was determined using kappa statistics. RESULTS: Our patients had no adverse reactions to iopanoic acid. The degree of biliary opacification was sufficient to perform three-dimensional and two-dimensional reconstructions in 29 patients (93.5%). Two patients were excluded from statistical analysis because cannulation of the common bile duct during retrograde cholangiography failed. Findings on endoscopic retrograde cholangiography in the remaining 29 patients were the following: choledocholithiasis (n = 14), common bile duct dilatation with no stones (n = 11), and normal bile ducts (n = 4). Sensitivity and specificity of oral-contrast-enhanced CT cholangiography for detection of choledocholithiasis were 92.9% (95% confidence interval [CI], 66.1-99.8%) and 100% (95% CI, 78.2-100%), respectively, for observer 1 and 85.7% (95% CI, 57.2-98.2%) and 100% (95% CI, 78.2-100%), respectively, for observer 2. Interobserver agreement was .92 (excellent). CONCLUSION: Helical CT cholangiography performed after oral administration of iopanoic acid appears promising for diagnosis of choledocholithiasis.
Asunto(s)
Colangiografía , Medios de Contraste/administración & dosificación , Cálculos Biliares/diagnóstico por imagen , Tomografía Computarizada por Rayos X , Administración Oral , Adulto , Anciano , Anciano de 80 o más Años , Colangiopancreatografia Retrógrada Endoscópica , Femenino , Humanos , Procesamiento de Imagen Asistido por Computador , Ácido Yopanoico/administración & dosificación , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Sensibilidad y EspecificidadRESUMEN
BACKGROUND: To demonstrate the radiologic-pathologic correlation of adenomyomatosis of gallbladder (GBA) and emphasize the role of high-resolution real-time ultrasound (RTUS) in the diagnosis of GBA. METHODS: Ten (four male and six female, mean age = 49 years) patients with proven GBA (three diffuse, three segmental, and four fundal) diagnosed by histopathology or confirmed by oral cholecystography (OCG) were reviewed. Radiologic studies included OCG (n = 8), RTUS (n = 8), and computed tomography (CT; n = 4). Six patients subsequently underwent cholecystectomy. RESULTS: Histopathologic correlation between pathologic specimens and OCG, RTUS, and CT was possible in six patients. The diagnostic criteria with ultrasound included numerous tiny intramural cysts containing echogenic foci with reverberation artifacts and associated segmental or diffuse gallbladder wall thickening. OCG with fatty meal demonstrated intramural diverticula. Localized fundal GBA was better visualized on RTUS and CT scan than on OCG. CONCLUSION: Accurate diagnosis of GBA may be made by either OCG or high-resolution RTUS preoperatively. CT scan may used as an alternative method to help make the diagnosis in equivocal cases.